REAL AD at the AD RIDDLE General Assembly in London
June 12, 2025
The REAL AD study was proud to take part in the AD RIDDLE consortium’s annual General Assembly meeting, held in London from June 9 to 11 and hosted by Imperial College. This event brought together the entire AD RIDDLE consortium—leading researchers, clinicians, and partners from across Europe—to share progress, exchange ideas, and shape the future of dementia research. More on AD RIDDLE and REAL AD’s role below.
What is AD RIDDLE?
The AD RIDDLE consortium (Alzheimer’s Disease: Real World Implementation, Deployment, and Validation of Early Detection Tools and Lifestyle Enhancement) is a pioneering European initiative aimed at transforming how Alzheimer’s disease is detected, prevented, and managed across healthcare systems. It brings together 24 international academic and industry partners, healthcare providers, regulatory bodies, and patient organisations, combining world-class expertise in research, clinical care, diagnostics, and advanced data analytics. Read more on AD RIDDLE here.
Mission and vision
AD RIDDLE is developing a user-friendly, modular toolbox that integrates digital cognitive assessments, blood-based biomarkers, and decision-support algorithms to enable earlier diagnosis and targeted intervention. Its flexible design supports adoption across diverse healthcare systems and advances research into cost-effective therapies for Alzheimer’s disease.
Why is the REAL AD study part of the AD RIDDLE consortium?
Being part of the consortium enables collaboration with leading experts across Europe while ensuring a diverse and representative participant sample. This enhances the scientific foundation and allows findings to be validated across different settings.
REAL AD also benefits from increased visibility among policymakers. For example, AD RIDDLE was recently represented at the Alzheimer Europe lunch debate at the European Parliament on June 3, 2025, helping influence dementia policy at a continental level. Read more here.
REAL AD participants in the AD RIDDLE Advisory Board
Public involvement is central to AD RIDDLE’s goals, especially since its tools are intended for real-world use. To include wider perspectives, national Advisory Boards involve members from outside the academic and clinical communities.
Nearly a year ago, REAL AD participants were invited to join the Swedish Advisory Board, and the response was outstanding—REAL AD participants now form the majority.
A heartfelt thank you to our Advisory Board members from REAL AD. Your insights help shape how the project communicates its work and ensures the tools and findings remain relevant, understandable, and accessible to the people most affected.
Highlights from the General Assembly meeting
From June 9 to 11, the annual General Assembly took place in London, hosted by Imperial College. The full project team gathered to assess progress and plan future directions. We were proud to see active contributions from the REAL AD team. Michael Schöll (study lead) participated in a panel on Communities of Practice, where different sites shared insights and challenges. Iris Bosch (project manager) presented updates from the Gothenburg site, which was met with great enthusiasm thanks to high participant engagement.
We deeply appreciate all our participants—your continued involvement drives the impact of our work and helps move dementia research forward.